MED365 plans medical equipment plant in Kosshy, eyes health tracker production

Published
Photo: Freedom

Kazakhstani medtech company MED365 (part of the Freedom ecosystem) plans to open its own manufacturing plant, with the long-term goal of launching a line of smart wearable health devices, according to Chingiz Kulakhmetov, CEO of Freedom Lab LLP and managing director of MED365.

«We started out in small production facilities. I realized that we needed to localize production and a small workshop was no longer sufficient; we wanted a full-scale plant,» he told Kursiv.media.

MED365’s flagship product is the Automated System for Medical Examinations (ASMO). The equipment assesses employees’ health before and after their shifts. The entire process takes just one minute: After the system identifies employees using facial recognition (Face ID), it measures their blood pressure, pulse and temperature and checks for alcohol consumption. An AI-powered module also evaluates fatigue levels and signs of drug intoxication. The system instantly records data in a digital log, then uses it to determine whether an individual is cleared for work. According to MED365, ASMO has conducted approximately 20 million pre-shift medical screenings over the past seven years. Enterprises across 14 regions of Kazakhstan currently use the system.

Speaking of localization, Kulakhmetov clarified that while Kazakhstan does not yet manufacture high-precision medical sensors, MED365 integrates them into a unified hardware-software system.

Kazakhstani-made components account for more than 70% of ASMO, qualifying the company as a domestic manufacturer.

Another potential area for development is technology transfer in telemedicine. According to Kulakhmetov, MED365 is working with international partners to localize production gradually. The process will move from packaging and assembly of large components to deeper localization and a full-scale manufacturing cycle.

The establishment of the production facility in Kosshy, in the Akmola region, was supported by a grant from the Science Fund. The company secured 350 million tenge ($789,555), which was allocated to payroll and the construction of the production site.

«We have fulfilled our obligations and plan to officially open the plant in the near future. Our goal is to establish a full production cycle here for our ASMO systems, as well as the assembly of Digital Med365 telemedicine solutions. In the future, we intend to manufacture hardware solutions for the entire Freedom ecosystem,» Kulakhmetov said.

The company is currently evaluating several types of wearable health-monitoring devices for local production and integration into the Freedom ecosystem.

«Before launching a product for the mass market, we want to test it ourselves. Eventually, we plan to provide these devices to bus and taxi drivers — with whom we already work through our medical screening system — to monitor their health. Unfortunately, there are too many cases of drivers experiencing sudden health problems while on duty,» Kulakhmetov explained.

The company plans to begin pilot testing the devices once production preparations are complete, with mass production potentially launching as early as 2027.

Read also